92P ARCHER 1050: PHASE III RANDOMIZED STUDY OF 1ST-LINE DACOMITINIB (D) VS GEFITINIB (G) FOR ADVANCED (ADV) NON-SMALL CELL LUNG CANCER (NSCLC) IN PATIENTS (PTS) WITH ACTIVATING EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) MUTATION(S) (Englisch)
- Neue Suche nach: Mok, T. S. K.
- Neue Suche nach: Nakagawa, K.
- Neue Suche nach: Rosell, R.
- Neue Suche nach: Wu, Y.
- Neue Suche nach: Trygstad, C.
- Neue Suche nach: Capizzi, R.
- Neue Suche nach: DeBenedetto, R.
- Neue Suche nach: Goldberg, Z.
- Neue Suche nach: Wang, T.
- Neue Suche nach: Antic, V.
- Neue Suche nach: Mok, T. S. K.
- Neue Suche nach: Nakagawa, K.
- Neue Suche nach: Rosell, R.
- Neue Suche nach: Wu, Y.
- Neue Suche nach: Trygstad, C.
- Neue Suche nach: Capizzi, R.
- Neue Suche nach: DeBenedetto, R.
- Neue Suche nach: Goldberg, Z.
- Neue Suche nach: Wang, T.
- Neue Suche nach: Antic, V.
In:
European Multidisciplinary Conference in Thoracic Oncology (EMCTO)
;
S39-S40
;
2013
-
ISSN:
- Aufsatz (Zeitschrift) / Print
-
Titel:92P ARCHER 1050: PHASE III RANDOMIZED STUDY OF 1ST-LINE DACOMITINIB (D) VS GEFITINIB (G) FOR ADVANCED (ADV) NON-SMALL CELL LUNG CANCER (NSCLC) IN PATIENTS (PTS) WITH ACTIVATING EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) MUTATION(S)
-
Beteiligte:Mok, T. S. K. ( Autor:in ) / Nakagawa, K. ( Autor:in ) / Rosell, R. ( Autor:in ) / Wu, Y. ( Autor:in ) / Trygstad, C. ( Autor:in ) / Capizzi, R. ( Autor:in ) / DeBenedetto, R. ( Autor:in ) / Goldberg, Z. ( Autor:in ) / Wang, T. ( Autor:in ) / Antic, V. ( Autor:in )
-
Erschienen in:LUNG CANCER -AMSTERDAM- ; 80 ; S39-S40
-
Verlag:
- Neue Suche nach: Elsevier Science B.V., Amsterdam.
-
Erscheinungsdatum:01.01.2013
-
Format / Umfang:S39-S40
-
ISSN:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Print
-
Sprache:Englisch
- Neue Suche nach: 616.99424
- Weitere Informationen zu Dewey Decimal Classification
-
Klassifikation:
DDC: 616.99424 -
Datenquelle:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Inhaltsverzeichnis – Band 80
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 1
-
Transformation to ``high grade'' neuroendocrine carcinoma as an acquired drug resistance mechanism in EGFR-mutant lung adenocarcinomaPopat, S. / Wotherspoon, A. / Nutting, C.M. / Gonzalez, D. / Nicholson, A.G. / O Brien, M. et al. | 2013
- 5
-
Accuracy of sentinel node biopsy in the staging of non-small cell lung carcinomas: Systematic review and meta-analysis of the literatureKermani, A.T. / Bagheri, R. / Tehranian, S. / Shojaee, P. / Sadeghi, R. / Krag, D.N. et al. | 2013
- 15
-
Farletuzumab in lung cancerThomas, A. / Maltzman, J. / Hassan, R. et al. | 2013
- 19
-
Mesenchymal stem cells in non-small cell lung cancer-Different from others? Insights from comparative molecular and functional analysesGottschling, S. / Granzow, M. / Kuner, R. / Jauch, A. / Herpel, E. / Xu, E.C. / Muley, T. / Schnabel, P.A. / Herth, F.J.F. / Meister, M. et al. | 2013
- 30
-
Adequacy of endobronchial ultrasound transbronchial needle aspiration samples in the subtyping of non-small cell lung cancerEsterbrook, G. / Anathhanam, S. / Plant, P.K. et al. | 2013
- 35
-
Reliability of EGFR and KRAS mutation analysis on fine-needle aspiration washing in non-small cell lung cancerBozzetti, C. / Naldi, N. / Nizzoli, R. / Azzoni, C. / Bortesi, B. / Zobbi, V. / Bottarelli, L. / Tiseo, M. / Gasparro, D. / Majori, M. et al. | 2013
- 39
-
Does CA125 binding to mesothelin impact the detection of malignant mesothelioma?Creaney, J. / Dick, I.M. / Dare, H. / Demelker, Y. / Nowak, A.K. / Musk, A.W. / Robinson, B.W.S. et al. | 2013
- 45
-
Diagnostic value of CEA and CYFRA 21-1 tumor markers in primary lung cancerOkamura, K. / Takayama, K. / Izumi, M. / Harada, T. / Furuyama, K. / Nakanishi, Y. et al. | 2013
- 50
-
Assessment of lung cancer mortality reduction after chest X-ray screening in smokers: A population-based cohort study in Varese, ItalyDominioni, L. / Poli, A. / Mantovani, W. / Pisani, S. / Rotolo, N. / Paolucci, M. / Sessa, F. / Conti, V. / D Ambrosio, V. / Paddeu, A. et al. | 2013
- 55
-
Factors associated with smoking abstinence after diagnosis of early stage lung cancerHopenhayn, C. / Christian, W.J. / Christian, A. / Studts, J. / Mullet, T. et al. | 2013
- 62
-
Concurrent chemoradiotherapy for large-volume locally-advanced non-small cell lung cancerWiersma, T.G. / Dahele, M. / Verbakel, W.F.A.R. / van de Ven, P.M. / de Haan, P.F. / Smit, E.F. / van Reij, E.J.F. / Slotman, B.J. / Senan, S. et al. | 2013
- 68
-
Phase I study of pemetrexed and cisplatin with concurrent high-dose thoracic radiation after induction chemotherapy in patients with unresectable locally advanced non-small cell lung cancerMornex, F. / Peignaux, K. / Germain, T. / Wautot, V. / Chouaki, N. et al. | 2013
- 75
-
Clinical outcomes with chemotherapy for advanced thymic carcinomaOkuma, Y. / Hosomi, Y. / Takagi, Y. / Sasaki, E. / Hishima, T. / Maeda, Y. / Shibuya, M. / Okamura, T. et al. | 2013
- 81
-
A dramatic lung cancer course in a patient with a rare EGFR germline mutation exon 21 V843I: Is EGFR TKI resistance predictable?Bourayou, N. / Tourani, J.-M. / Demierre, N. / Zoete, V. / Michielin, O. / Stauffer, E. / Zimmermann, D.R. / Betticher, D.C. / Peters, S. et al. | 2013
- 85
-
Aurora-B overexpression is correlated with aneuploidy and poor prognosis in non-small cell lung cancerTakeshita, M. / Koga, T. / Takayama, K. / Ijichi, K. / Yano, T. / Maehara, Y. / Nakanishi, Y. / Sueishi, K. et al. | 2013
- 91
-
Network-based approach identified cell cycle genes as predictor of overall survival in lung adenocarcinoma patientsLi, Y. / Tang, H. / Sun, Z. / Bungum, A.O. / Edell, E.S. / Lingle, W.L. / Stoddard, S.M. / Zhang, M. / Jen, J. / Yang, P. et al. | 2013
- 99
-
Solitary pulmonary metastasis from lung cancer harboring EML4-ALK after a 15-year disease-free intervalTomizawa, K. / Ito, S. / Suda, K. / Fukui, T. / Usami, N. / Hatooka, S. / Kuwano, H. / Yatabe, Y. / Mitsudomi, T. et al. | 2013
- 102
-
High-dose, pulsatile erlotinib in two NSCLC patients with leptomeningeal metastases-One with a remarkable thoracic response as wellKuiper, J.L. / Smit, E.F. et al. | 2013
- 106
-
When a thymic carcinoma ``becomes'' a GISTRossi, V. / Donini, M. / Sergio, P. / Passalacqua, R. / Rossi, G. / Buti, S. et al. | 2013
- 109
-
Long-term gefitinib treatment of occult lung carcinoma with multiple brain metastasesKobayashi, T. / Takeda, M. / Marumo, S. / Koshimo, Y. / Teranishi, T. / Higami, Y. / Kato, M. et al. | 2013
- 111
-
Continuous pemetrexed treatment for brain metastasis in non-small cell lung cancer-A report of two casesOchi, N. / Yamane, H. / Yamagishi, T. / Takigawa, N. et al. | 2013
- 113
-
First case report of intrathecal panitumumab for treatment of meningeal carcinomatousis in an EGFR mutant lung adenocarcinoma patientHollebecque, A. / Levy, A. / Broutin, S. / Lemare, F. / Gazzah, A. / Desmaris, R. / Chenailler, C. / Elbaum, M. / Besse, B. / Paci, A. et al. | 2013
- 115
-
Lung surgery in the elderly todayRocco, G. / Weder, W. et al. | 2013
- 120
-
Epidermal growth factor receptor tyrosine kinase inhibitors in the treatment of NSCLCPallis, A.G. / Syrigos, K.N. et al. | 2013
- 131
-
Genetic polymorphisms of TERT and CLPTM1L and risk of lung cancer-A case-control study in a Chinese populationMyneni, A.A. / Chang, S.-C. / Niu, R. / Liu, L. / Ochs-Balcom, H.M. / Li, Y. / Zhang, C. / Zhao, B. / Shi, J. / Han, X. et al. | 2013
- 138
-
Lung cancer mortality in European men: Trends and predictionsMalvezzi, M. / Bosetti, C. / Rosso, T. / Bertuccio, P. / Chatenoud, L. / Levi, F. / Romano, C. / Negri, E. / La Vecchia, C. et al. | 2013
- 146
-
Lung parenchymal invasion in pulmonary carcinoid tumor: An important histologic feature suggesting the diagnosis of atypical carcinoid and poor prognosisHa, S.Y. / Lee, J.J. / Cho, J. / Hyeon, J. / Han, J. / Kim, H.K. et al. | 2013
- 153
-
Legal claims for malignant mesothelioma: Dealing with all casesvan der Bij, S. / Baas, P. / van de Vijver, M.J. / de Mol, B.A.J.M. / Burgers, J.A. et al. | 2013
- 159
-
Preexisting interstitial lung disease is inversely correlated to tumor epidermal growth factor receptor mutation in patients with lung adenocarcinomaFujimoto, D. / Tomii, K. / Otoshi, T. / Kawamura, T. / Tamai, K. / Takeshita, J. / Tanaka, K. / Matsumoto, T. / Monden, K. / Nagata, K. et al. | 2013
- 165
-
Improved identification of peripheral lung tumors by using diffuse reflectance and fluorescence spectroscopySpliethoff, J.W. / Evers, D.J. / Klomp, H.M. / van Sandick, J.W. / Wouters, M.W. / Nachabe, R. / Lucassen, G.W. / Hendriks, B.H.W. / Wesseling, J. / Ruers, T.J.M. et al. | 2013
- 172
-
Long-term clinical experience of high-dose ablative lung radiotherapy: High pre-treatment [18F]Fluorodeoxyglucose-positron emission tomography maximal standardized uptake value of the primary tumor adversely affects treatment outcomeLee, D.S. / Kim, Y.S. / Yoo, I.R. / Kang, Y.N. / Kim, S.J. / Oh, J.K. / Kim, Y.K. / Wang, Y.P. / Park, J.G. / Kang, J.-H. et al. | 2013
- 179
-
Patterns of failure after postoperative radiotherapy for incompletely resected (R1) non-small cell lung cancer: Implications for radiation target volume designOlszyna-Serementa, M. / Socha, J. / Wierzchowski, M. / Kepka, L. et al. | 2013
- 185
-
Pemetrexed and carboplatin, an active option in first-line treatment of elderly patients with advanced non-small cell lung cancer (NSCLC): A phase II trialGervais, R. / Robinet, G. / Clement-Duchene, C. / Denis, F. / El Kouri, C. / Martin, P. / Chouaki, N. / Bourayou, N. / Morere, J.-F. et al. | 2013
- 191
-
Real world impact of epidermal growth factor receptor mutation status on treatment patterns in patients with non-small cell lung cancerSun, J.-M. / Rampal, S. / Lee, G. / Lee, J. / Choi, Y.-L. / Parasuraman, B. / Guallar, E. / Cho, J. / Shim, Y.M. et al. | 2013
- 197
-
Bevacizumab and weekly paclitaxel for non-squamous non small cell lung cancer patients: A retrospective studyHabib, S. / Delourme, J. / Dhalluin, X. / Petyt, G. / Tacelli, N. / Scherpereel, A. / Lafitte, J.-J. / Cortot, A.B. et al. | 2013
- 203
-
The lung cancer patient at the emergency department: A three-year retrospective studyGorham, J. / Ameye, L. / Berghmans, T. / Sculier, J.P. / Meert, A.P. et al. | 2013
- 209
-
CD4/CD8 co-expression shows independent prognostic impact in resected non-small cell lung cancer patients treated with adjuvant radiotherapyHald, S.M. / Bremnes, R.M. / Al-Shibli, K. / Al-Saad, S. / Andersen, S. / Stenvold, H. / Busund, L.-T. / Donnem, T. et al. | 2013
- 216
-
PARP1 impact on DNA repair of platinum adducts: Preclinical and clinical read-outsOlaussen, K.A. / Adam, J. / Vanhecke, E. / Vielh, P. / Pirker, R. / Friboulet, L. / Popper, H. / Robin, A. / Commo, F. / Thomale, J. et al. | 2013
- 223
-
Serum miR-142-3p is associated with early relapse in operable lung adenocarcinoma patientsKaduthanam, S. / Gade, S. / Meister, M. / Brase, J.C. / Johannes, M. / Dienemann, H. / Warth, A. / Schnabel, P.A. / Herth, F.J.F. / Sultmann, H. et al. | 2013
- 228
-
The efficacy of tacrolimus and sirolimus in heavily pre-treated unresectable thymic malignanciesPayne, S.J.L. / Krell, J. / Wilson, P. / Ansell, W. / Frampton, A.E. / Stebbing, J. / Shamash, J. et al. | 2013
- 230
-
Micropapillary components in a lung adenocarcinoma predict stump recurrence 8 years after resection: A case reportWatanabe, M. / Yokose, T. / Tetsukan, W. / Imai, K. / Tsuboi, M. / Ito, H. / Ishikawa, Y. / Yamada, K. / Nakayama, H. / Fujino, S. et al. | 2013
- 235
-
Uncommon Epidermal Growth Factor Receptor mutations in non-small cell lung cancer and their mechanisms of EGFR tyrosine kinase inhibitors sensitivity and resistanceMassarelli, E. / Johnson, F. M. / Erickson, H. S. / Wistuba, I. I. / Papadimitrakopoulou, V. et al. | 2013
- 242
-
CNS metastases in non-small-cell lung cancer: Current role of EGFR-TKI therapy and future perspectivesBerger, L. A. / Riesenberg, H. / Bokemeyer, C. / Atanackovic, D. et al. | 2013
- 249
-
Personalized therapy on the horizon for squamous cell carcinoma of the lungKim, H. S. / Mitsudomi, T. / Soo, R. A. / Cho, B. C. et al. | 2013
- 256
-
Tumor-associated macrophages in thoracic malignanciesLievense, L. A. / Bezemer, K. / Aerts, J. G. J. V. / Hegmans, J. P. J. J. et al. | 2013
- 263
-
K-ras 4A and 4B mRNA levels correlate with superoxide in lung adenocarcinoma cells, while at the protein level, only mutant K-ras 4A protein correlates with superoxideCalvert, R. J. / Gupta, M. / Maciag, A. / Shiao, Y. H. / Anderson, L. M. et al. | 2013
- 270
-
Tobacco specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone suppresses a newly identified anti-tumor IGFBP-3/IGFBP-3R system in lung cancer cellsHarada, A. / Jogie-Brahim, S. / Oh, Y. et al. | 2013
- 278
-
ALK gene translocations and amplifications in brain metastases of non-small cell lung cancerPreusser, M. / Berghoff, A. S. / Ilhan-Mutlu, A. / Magerle, M. / Dinhof, C. / Widhalm, G. / Dieckmann, K. / Marosi, C. / Wohrer, A. / Hackl, M. et al. | 2013
- 284
-
Efficacy of two fluorescence in situ hybridization (FISH) probes for diagnosing malignant pleural effusionsRosolen, D. C. B. / Kulikowski, L. D. / Bottura, G. / Nascimento, A. M. / Acencio, M. / Teixeira, L. / Vargas, F. S. / Sales, R. K. / Antonangelo, L. et al. | 2013
- 289
-
Clinical application of immunocytochemical detection of ALK rearrangement on cytology slides for detection or screening of lung adenocarcinomaTanaka, H. / Tone, K. / Hayashi, A. / Morimoto, T. / Taima, K. / Tanaka, Y. / Nakagawa, H. / Takanashi, S. / Okumura, K. / Kurose, A. et al. | 2013
- 293
-
Screening for brain metastases in patients with stage III non-small cell lung cancer: Is there additive value of magnetic resonance imaging above a contrast-enhanced computed tomography of the brain?Hendriks, L. E. L. / Bootsma, G. P. / de Ruysscher, D. K. M. / Scheppers, N. A. M. / Hofman, P. A. M. / Brans, B. T. / Dingemans, A. M. C. et al. | 2013
- 298
-
The addition of amifostine to carboplatin and paclitaxel based chemoradiation in locally advanced non-small cell lung cancer: Long-term follow-up of Radiation Therapy Oncology Group (RTOG) randomized trial 9801Lawrence, Y. R. / Paulus, R. / Langer, C. / Werner-Wasik, M. / Buyyounouski, M. K. / Komaki, R. / Machtay, M. / Smith, C. / Axelrod, R. S. / Wasserman, T. et al. | 2013
- 306
-
EGFR-tyrosine kinase inhibitor treatment beyond progression in long-term Caucasian responders to erlotinib in advanced non-small cell lung cancer: A case-control study of overall survivalFaehling, M. / Eckert, R. / Kamp, T. / Kuom, S. / Griese, U. / Strater, J. / Ott, G. / Spengler, W. et al. | 2013
- 313
-
Phase II study of camtobell inj. (belotecan) in combination with cisplatin in patients with previously untreated, extensive stage small cell lung cancerLim, S. / Cho, B. C. / Jung, J. Y. / Kim, G. M. / Kim, S. H. / Kim, H. R. / Kim, H. S. / Lim, S. M. / Park, J. S. / Lee, J. H. et al. | 2013
- 319
-
Prospective, multicenter, randomized, independent-group, open-label phase II study to investigate the efficacy and safety of three regimens with two doses of sagopilone as second-line therapy in patients with stage IIIB or IV non-small-cell lung cancerHeigener, D. F. / von Pawel, J. / Eschbach, C. / Brune, A. / Schmittel, A. / Schmelter, T. / Reck, M. / Fischer, J. R. et al. | 2013
- 326
-
Impact of renal function on treatment options and outcomes in advanced non-small cell lung cancerKutluk Cenik, B. / Sun, H. / Gerber, D. E. et al. | 2013
- 333
-
XBP1 promoter polymorphism modulates platinum-based chemotherapy gastrointestinal toxicity for advanced non-small cell lung cancer patientsPeng, J. / Chen, Y. Y. / Yang, L. X. / Zhao, X. Y. / Gao, Z. Q. / Yang, J. / Wu, W. T. / Wang, H. J. / Wang, J. C. / Qian, J. et al. | 2013
- 339
-
A rare case of squamous cell carcinoma of the lung harbouring ALK and BRAF activating mutationsAlrifai, D. / Popat, S. / Ahmed, M. / Gonzalez, D. / Nicholson, A. G. / Parcq, J. d. / Benepal, T. et al. | 2013
- 341
-
Radiofrequency ablation for non-small-cell lung cancer in a single-lung patient: Case report and review of the literatureModesto, A. / Giron, J. / Massabeau, C. / Sans, N. / Berjaud, J. / Mazieres, J. et al. | 2013
- 344
-
Successful treatment with erlotinib of severe neutropenia induced by gefitinib in a patient with advanced non-small cell lung cancerAraya, T. / Kasahara, K. / Demura, Y. / Matsuoka, H. / Nishitsuji, M. / Nishi, K. et al. | 2013
- 347
-
Pemetrexed-induced neutropenic enteritis and severe cutaneous hyperpigmentation in a patient with malignant pleural mesotheliomaBuchinger, K. / Stahel, R. / Niggemeier, V. / Gubler, C. / Franzen, D. et al. | 2013
- 350
-
Coffee consumption and the risk of cancer developmentKapoor, S. et al. | 2013
- 350
-
A closer look at the effects of postoperative radiotherapy by stage and nodal status: Updated results of an individual participant data meta-analysis in non-small-cell lung cancerBurdett, S. / Rydzewska, L. / Tierney, J. F. / Fisher, D. J. et al. | 2013
- 352
-
Delivery optimization of erlotinib according to toxicity: May clinical practice go beyond research?Passaro, A. / Fasano, M. / Bria, E. / Morgillo, F. / Cantile, F. / Alesini, D. / Pellegrino, A. / Cortesi, E. / Ciardiello, F. et al. | 2013
- S4
-
11P THE INHIBITION OF CD26/DPP4 REDUCES LUNG TUMOUR GROWTH IN MICEJang, J. / Arni, S. / Perparim, L. / Graf, R. / Clavien, P. / De Meester, I. / Hillinger, S. / Weder, W. / Jungraithmayr, W. et al. | 2013
- S5
-
14 CIRCULATING DNA IN LUNG CANCER: EPIGENETIC MARKERS FOR DIAGNOSTICS AND POST-TREATMENT FOLLOW-UPPonomaryova, A. / Rykova, E. / Cherdyntseva, N. / Dobrodeev, A. / Skvortsova, T. / Zav'yalov, A. / Tuzikov, S. / Vlassov, V. / Laktionov, P. et al. | 2013
- S7
-
17P CLINICAL AND PROGNOSTIC IMPLICATIONS DUE TO DELETIONS IN THE P53 GENE IN NON SMALL CELL LUNG CANCER PATIENTSMir, A. R. / Javaid, J. / Masroor, M. / Ahmad, I. / Yadav, P. / Zuberi, M. / Lone, M. / Mohan, A. / Ray, P. C. / Saxena, A. et al. | 2013
- S8
-
20P A 10 YEARS SURVEY OF LUNG CANCER IN SHAHID RAJAI RADIOTHERAPY CENTER IN NORTH OF IRANMoslemi, D. / Tayebi, M. T. / Sum, S. / Monfared, A. S. et al. | 2013
- S10
-
23O SERUM MICRORNA AS A DIAGNOSTIC TEST FOR EARLY LUNG CANCERVeronesi, G. / Bianchi, F. / Rampinelli, C. / Maisonneuve, P. / Dama, E. / Bonizzi, G. / Bellomi, M. / Spaggiari, L. / Travaini, L. / Di Fiore, P. et al. | 2013
- S11
-
26PD FORETINIB (GSK1363089), A MULTIKINASE INHIBITOR OF MET AND VEGFS, OVERCOMES RESISTANCE TO BEVACIZUMAB IN AN IN VIVO MODEL OF ACQUIRED BEVACIZUMAB RESISTANCEXie, M. / He, C. S. et al. | 2013
- S12
-
29P RNA SEQ REVEALS GENE EXPRESSION PROFILES OF NON-SMALL CELL LUNG CANCERHan, S. / Lee, H. / Lee, S. / Kim, W. J. / Oh, Y. / Lee, J. S. / Lee, S. D. / Choi, C. / Lee, J. C. et al. | 2013
- S13
-
32P PIGMENT EPITHELIUM-DERIVED FACTOR ENHANCES TUMOR RESPONSE TO RADIATION BY NORMALIZING VASCULATURE IN A XENOGRAFTED MODEL OF LUNG CANCERXu, Z. / Peng, F. / Yu, Z. / Zuo, Y. / Chen, Y. / Wang, J. / Hu, X. / Zhou, Q. / Bao, Y. / Chen, M. et al. | 2013
- S16
-
37O 18-F FDG PET TOTAL GLYCOLYTIC VOLUME IN THYMIC EPITHELIAL NEOPLASMS EVALUATION: AN EASILY REPRODUCIBLE IMAGE BIOMARKERBertolaccini, L. / Lanzi, E. / Viti, A. / Chauvie, S. / Bianchi, A. / Cavallo, A. / Terzi, A. et al. | 2013
- S18
-
41P IS THERE ANY ROLE FOR CIRCULATING TUMOR CELLS IN PATIENTS WITH SMALL CELL LUNG CANCER (SCLC)?Olmedo, E. / Earl, J. / Guerrero, C. / Longo, F. / Alcalde, R. / Soria, A. / Grande, E. / Plana, N. / Carrato, A. / Garrido, P. et al. | 2013
- S19
-
44P INVESTIGATING GENDER AS PROGNOSTIC FACTOR IN PATIENTS WITH LIMITED DISEASE SCLC TREATED WITH CHEMORADIOTHERAPYManapov, F. et al. | 2013
- S20
-
47P TREATMENT OPTIONS FOR SMALL CELL LUNG CANCER: DOES LANREOTIDE REPRESENT A NEW CHOICE?Franchina, T. / Proto, C. / Russo, A. / Chiofalo, G. / Scimone, A. / Adamo, V. et al. | 2013
- S23
-
52P LIMITED RESECTION PROVIDES WORSE PROGNOSIS IN SOLID TYPE CLINICAL STAGE IA NON SMALL CELL LUNG CANCERJeon, H. W. / Kim, K. S. / Moon, Y. K. / Sung, S. W. / Park, H. J. / Wang, Y. P. / Park, J. K. et al. | 2013
- S26
-
57PD NEOADJUVANT CHEMORADIOTHERAPY FOR LOCALLY ADVANCED NON SMALL CELL LUNG CANCERToker, A. / Saglam, E. K. / Ozkan, B. / Akgun, Z. / Tuncay, E. / Eralp, Y. / Ziyade, S. et al. | 2013
- S28
-
63P CISPLATIN-DOCETAXEL FOLLOWED BY WEEKLY DOCETAXEL IN ASSOCIATION WITH THORACIC RADIOTHERAPY IN LOCALLY ADVANCED NSCLC: PRELIMINARY RESULTS OF A PHASE II TRIALScotti, V. / Bastiani, P. / Loi, M. / Franzese, C. / Agresti, B. / Meacci, F. / De Luca Cardillo, C. / Paoletti, L. / Furfaro, I. F. / Biti, G. et al. | 2013
- S30
-
66O EGFR MUTATED PATIENTS (PTS): DIFFERENT PATTERN AND OUTCOME OF METASTATIC BONE DISEASE (MBD) AND BRAIN METASTASIS (BM)?Hendriks, L. / Vosse, B. / Speel, E. / Bootsma, G. / Westenend, M. / de Vries, G. / Pitz, C. / Dingemans, A. et al. | 2013
- S32
-
71PD REVERSIBLE EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASES INIHIBITORS (REGFR-TKIS), ERLOTINIB OR GEFITINIB, COMPARED TO CHEMOTHERAPY (CHT) IN PREVIOUSLY TREATED METASTATIC NON SMALL CELL LUNG CANCER (NSCLC) PATIENTS (PTS): A META-ANALYSISPochesci, A. / Trenta, P. / Iacovelli, R. / Palleschi, M. / Prete, A. A. / Magri, V. / Mosillo, C. / Pellegrino, D. / De Benedetto, A. / Cortesi, E. et al. | 2013
- S33
-
74P RELATION BETWEEN CYTOCHROME P450 (CYP) POLYMORPHISMS AND BIO-AVAILABILITY AND ADVERSE EVENTS (AE) OF TYROSINE KINASE INHIBITORS (TKIS)Brouns, A. / Soetekouw, P. / Van den Borne, B. / Wijnen, P. / Bekers, O. / Lankheet, N. / Huitema, A. / Houben, R. / Aerts, J. / Dingemans, A. et al. | 2013
- S35
-
79P ERLOTINIB EFFICACY IN PRETREATED EGFR WILD-TYPE CAUCASIAN PATIENTS: A MULTIVARIATE ANALYSIS IDENTIFIYNG FAVOURABLE PROGNOSTIC/PREDICTIVE FACTORSGori, B. / Del Signore, E. / Fulvi, A. / Ricciardi, S. / D'Antonio, C. / Migliorino, M. R. / Condo, S. / De Santis, S. / Giannarelli, D. / de Marinis, F. et al. | 2013
- S36
-
82P COMBINED MODALITY THERAPY OF ADVANCED NON-SMALL-CELL LUNG CANCER: A SINGLE INSTITUTION EXPERIENCEResuli, B. et al. | 2013
- S37
-
85P BENEFIT OF MAINTENANCE THERAPY IN PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG CANCER (NSCLC) ACCORDING TO RESPONSE TO FIRST LINE THERAPYGarde, J. / Garcia, J. / Marin, S. / Berzosa, M. / Sangrador, C. / Hidalgo, J. / Piera, N. / Juan, O. / Llombart, A. et al. | 2013
- S38
-
88P ROS1(+) LUNG ADENOCARCINOMA TREATED WITH CRIZOTINIB - CASE REPORTMatsouka, F. / Stamatopoulos, D. A. / Katsikas, M. / Bakogiannis, C. / Kosmidis, P. A. et al. | 2013
- S39
-
92P ARCHER 1050: PHASE III RANDOMIZED STUDY OF 1ST-LINE DACOMITINIB (D) VS GEFITINIB (G) FOR ADVANCED (ADV) NON-SMALL CELL LUNG CANCER (NSCLC) IN PATIENTS (PTS) WITH ACTIVATING EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) MUTATION(S)Mok, T. S. K. / Nakagawa, K. / Rosell, R. / Wu, Y. / Trygstad, C. / Capizzi, R. / DeBenedetto, R. / Goldberg, Z. / Wang, T. / Antic, V. et al. | 2013
- S42
-
100P THORACOSCOPIC OUTPATIENT WEDGE LUNG RESECTION: IS IT A SAFE AND EFFECTIVE PROCEDURE?on behalf of Pneumoclub Ticino / Cafarotti, S. / Giuliani, M. / Mattarelli, E. / Carboni, G. / Karoubi, G. / Dutly, A. et al. | 2013
- S43
-
102P LUNG METASTASECTOMY IN CRC PATIENTS: A PORTUGUESE SINGLE-INSTITUTION EXPERIENCEMiguel, I. / Marques, T. / Freire, J. et al. | 2013
- S44
-
105P A UNIQUE CASE OF SALIVARY PLEOMORPHIC ADENOMA CHANGING INTO HYALINIZING CLEAR CELL CARCINOMA WITH PULMONARY METASTASISRaveglia, F. / Rizzi, A. / Luciani, A. / Biglioli, F. / Baisi, A. et al. | 2013
- S46
-
108P THE VALUE OF THE GLASGOW PROGNOSTIC SCORE IN PATIENTS UNDERGOING SURGERY FOR MALIGNANT PLEURAL MESOTHELIOMAHoda, M. / Ghanim, B. / Klikovits, T. / Hegedus, B. / Dome, B. / Arns, M. / Pohl, W. / Filipits, M. / Klepetko, W. / Berger, W. et al. | 2013
- S47
-
111P EFFECTIVENESS OF MESOTHELIN FAMILY PROTEINS AND OSTEOPONTIN FOR MALIGNANT MESOTHELIOMAPantazopoulos, I. / Boura, P. / Xanthos, T. / Sarris, E. / Syrigos, K. N. et al. | 2013
- S49
-
115P ORAL ETOPOSIDE IN PRETREATED ADVANCED THYMOMA AND THYMIC CARCINOMA. A FRENCH EXPERIENCEBoutros, C. / Fayard, F. / Besse, B. et al. | 2013
- S50
-
118P PRIMARY PLEURAL LYMPHOMA: A CASE OF PRIMARY PLEURAL T-CELL NON-HODGKIN'S LYMPHOMA WITH EMPYEMA OF THE CHESTHussein, H. S. / Ahmed, M. E. / Ahmed, H. M. et al. | 2013
- S52
-
121P ROLE OF EXERCISE FOR THE MANAGEMENT OF CANCER-RELATED FATIGUE IN LUNG CANCER: SYSTEMATIC REVIEWParamanandam, V. S. / Dunn, V. et al. | 2013
- S54
-
124P THYMECTOMY BETWEEN VIDEO-ASSISTED THORACOSCOPY AND DIFFERENT OPEN SURGICAL TECHNIQUESMuhammad, M. I. A. et al. | 2013
- S55
-
127P DOSE PERTURBATION CAUSED BY GOLD FIDUCIAL CT ARTIFACTS DURING PROTON LUNG RADIATION THERAPYGueorguiev, G. / Sharp, G. / Mahd, M. et al. | 2013
- S57
-
Author Index| 2013
- S63
-
Keyword Index| 2013
-
33P GENE EXPRESSION PROFILE OF CLASSICAL (CD14++CD16-) MONOCYTES IN PATIENTS WITH NON-SMALL CELL LUNG CANCER IS ALTERED BY CHEMOTHERAPYMcCarthy, F. / Ghirelli, C. / Zollinger, R. / Phillips, M. / Candido, J. / Trehy, R. / Roshani, R. / Steele, J. / Hagemann, T. et al. | 2013
-
69O MOLECULAR FOLLOW UP OF AN ITALIAN COHORT OF EGFR MUTATED PATIENTS PROGRESSING AFTER TREATMENT WITH ORAL TYROSINE KINASE INHIBITORSGori, B. / de Marinis, F. / Graziano, P. / Ricciardi, S. / Fulvi, A. / Signore, E. D. / Mancuso, A. / Migliorino, M. R. / Gasbarra, R. / Leone, A. et al. | 2013
-
72PD IMPACT OF EGFR STATUS ON THE PRESENCE OF LIVER METASTASES (LM) FROM NON-SMALL CELL LUNG CANCER (NSCLC) AND SURVIVAL IMPLICATIONSAlvarez, E. C. / Lozano, M. D. / Fusco, J. P. / Arevalo, E. / Rua, O. E. C. / Zubiri, L. / Martin, P. / Lopez-Picazo, J. M. / Gil-Bazo, I. et al. | 2013
-
86P PROGNOSTIC FACTORS IN METASTATIC NON SMALL CELL LUNG CANCER: A SINGLE INSTITUTION EXPERIENCEBenbrahim, Z. / Amaadour, L. / Arifi, S. / Abda, N. / Nejjari, C. / Mellas, N. / El Mesbahi, O. et al. | 2013
-
94P PREVALENCE OF ACTIVATING EGFR MUTATIONS IN PATIENTS WITH ADENOCARCINOMA OF LUNG CANCER IN ALGERIAN SERIESBensaou, M. G. / Allalouche, N. M. / Dlim, N. G. / Bouzid, K. et al. | 2013
-
114P SURGICAL TREATMENT OF ADENOCYSTIC CANCER OF THE TRACHEAMosina, N. V. / Mosin, I. V. / Lukina, O. V. et al. | 2013
-
117P THYMOMA: A REVIEW OF THE CLINICAL AND PATHOLOGICAL FINDINGS IN 30 CASESGradica, F. / Fype, E. / Kokici, F. / Kapisyzi, P. / Rakacolli, M. / Peposhi, I. / Argjiri, D. / Dilko, E. / Cami, A. / Tafa, O. et al. | 2013
-
125P PHARMACOKINETICS STUDY OF BRONCHIAL ARTERY INFUSION CHEMOTHERAPY IN DOG LUNG ON THE BASIS OF MICRODIALYSIS TECHNIQUEAn, X. / Wang, J. / Dong, W. et al. | 2013
-
Drug Index| 2013
-
27 EXPRESSION OF NOTCH-1 IN EGFR-TKI ACQUIRED RESISTANT LUNG ADENOCARCINOMAXie, M. / He, C. S. / Hou, J. H. et al. | 2013
-
48O TREATMENT OF MULTIPLE PRIMARY LUNG CANCERS (MLPC) WITH STEREOTACTIC ABLATIVE RADIOTHERAPY (SABR)Griffioen, G. H. M. J. / Lagerwaard, F. J. / Haasbeek, C. J. A. / Smit, E. F. / Slotman, B. J. / Senan, S. et al. | 2013
-
67O ARE FIRST-LINE PLATINUM-BASED (PT) REGIMENS IMPROVING SURVIVAL IN COMPARISON WITH NON-PLATINUM (NPT) CHEMOTHERAPY (CT) IN ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)? A META-ANALYSIS (MA) OF RANDOMISED TRIALSBerghmans, T. / Paesmans, M. / Meert, A. P. / CsToth, I. / Sculier, J. P. et al. | 2013
-
75P REDUCED FOLATE CARRIER (RFC) AS A PREDICTIVE MARKER FOR RESPONSE TO PEMETREXED IN ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)Fernandez, C. A. / Arnillas, Q. P. / Echeverria, A. L. R. / Rubi, D. R. / Fombella, J. P. B. / Gonzalez, E. E. / Palicio, N. V. et al. | 2013
-
78P AVAILABILITY OF EGFR MUTATION STATUS AT FIRST ONCOLOGY CONSULTATION FOR ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER PATIENTS. A PILOT EXPERIENCE FROM THE CHRISTIEEvans, M. / Summers, Y. / Taylor, P. / Harris, M. / Bayman, N. / Faivre-Finn, C. / Sheikh, H. / Burt, P. / Blackhall, F. / Califano, R. et al. | 2013
-
80P MANAGEMENT OF ELDERLY PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER: A SINGLE CENTRE EXPERIENCEFruh, M. / Besrour, H. / Gillessen, S. / Hitz, F. / Joerger, M. / Cerny, T. / Savidan, A. / Ess, S. et al. | 2013
-
83P PHYSICAL EXERCISE TRAINING IN PATIENTS WITH NON SMALL CELL LUNG CANCER (NSCLC): RESULTS OF A FEASIBILITY STUDYWiskemann, J. / Kuhr, L. / Hummler, S. / Abel, U. / Zoz, M. / Ulrich, C. / Thomas, M. et al. | 2013
-
106P PROTEOMIC ANALYSIS SHOWED HEAT SHOCK 70 KDA PROTEIN AND 78 KDA GLUCOSE-REGULATED PROTEIN WERE UP-REGULATED IN HUMAN MALIGNANT PLEURAL MESOTHELIOMA CELLSKuramitsu, Y. / Tominaga, W. / Baron, B. / Kitagawa, T. / Nakamura, K. et al. | 2013
-
119P SURVIVAL ANALYSIS IN PATIENTS WITH MALIGNANT AIRWAY STENOSIS REFERRED FOR ENDOBRONCHIAL INTERVENTION AND SUBSEQUENT ANTI-CANCER TREATMENTDudzevicius, V. / Azribi, F. / Aynsley, E. / Sathyamurthy, R. / Bapusamy, A. et al. | 2013
-
5P EGFR GENE MUTATION IN ADVANCED NON-SMALL CELL LUNG CANCERMehmood, T. / Rashid, A. / Usman, S. / Irfan, M. / Haider, I. / Rehman, K. et al. | 2013
-
30P DIFFERENTIAL MICRORNA EXPRESSION AND TARGET GENES BETWEEN LUNG CANCER AND NORMAL TISSUELee, H. / Song, S. / Lim, K. / Han, S. / Kim, W. J. / Oh, Y. / Lee, J. S. et al. | 2013
-
54P A PHASE I/II TRIAL OF CONCURRENT CHEMO-RADIATION WITH DOSE-ESCALATED RADIOTHERAPY IN PATIENTS WITH STAGE II OR STAGE III NON-SMALL CELL LUNG CANCERLandau, D. B. / Laurence, V. / Illsley, M. / Hughes, S. / Miles, E. / Ngai, Y. / Hughes, L. / Khan, I. / Mayles, P. / Fenwick, J. et al. | 2013
-
56O OUTCOMES OF CONCURRENT CHEMO-RADIOTHERAPY FOR LARGE-VOLUME STAGE III NSCLCDahele, M. / Wiersma, T. / Verbakel, W. F. A. R. / van de Ven, P. / de Haan, P. / Smit, E. / van Reij, E. / Slotman, B. J. / Senan, S. et al. | 2013
-
59PD PRE- AND INTRAOPERATIVE PHOTODYNAMIC THERAPY IN LOCALLY ADVANCED CENTRAL NSCLCAkopov, A. / Rusanov, A. / Chistiakov, I. / Urtenova, M. / Gerasin, A. / Kazakov, N. et al. | 2013
-
65O HER2 IN NON-SMALL CELL LUNG CARCINOMASGatalica, Z. / Gupta, P. / Ghazalpour, A. / Johnston, C. / Voss, A. / Basu, G. / Bender, R. et al. | 2013
-
98P LONG TERM FOLLOW UP OF PATIENTS TREATED WITH CYBERKNIFE STEREOTACTIC BODY RADIOTHERAPY FOR OLIGOMETASTATIC LUNG CANCERBeltramo, G. / Bergantin, A. / Martinotti, A. S. / Vite, C. / Ria, F. / Invernizzi, M. / Bianchi, L. C. et al. | 2013
-
104P RISK FACTORS OF LUNG METASTASES FROM ADVANCED INVASIVE DUCTAL CARCINOMA OF THE BREASTLumachi, F. / Marino, F. / Chiara, G. B. / Basso, S. M. M. et al. | 2013
-
7P BONE MARROW MESENCHYMAL STEM CELLS DELETERIOUSLY AFFECT LUNG CANCER CELL LINESGottfried, M. / Drucker, L. / Mishaeli, M. / Zismanov, V. et al. | 2013
-
8P P53 AB-1 (CLONE PAB 240) MAY BE USED IN BRONCHIAL-PULMONARY CARCINOMAS TO SCREEN MUTATED PROTEINCarvalho, L. / Alarcao, A. / Mota, P. / Costa, J. R. / Fonseca, J. P. / Ladeirinha, A. F. / Ferreira, T. / D'Aguiar, M. J. et al. | 2013
-
6P CHEMOTHERAPY-ENFORCED EXPRESSION OF CANCER STEM CELL MARKERS IN A SERIES OF THREE SCLC CELL LINES OBTAINED DURING CLINICAL TREATMENTHamilton, G. / Ulsperger, E. / Geissler, K. / Zeillinger, R. / Olszewski, U. et al. | 2013
-
10P OVEREXPRESSION OF REGULATOR OF G-PROTEIN SIGNALING 5 REDUCES THE SURVIVAL RATE AND ENHANCES THE RADIATION RESPONSE OF HUMAN LUNG CANCER CELLSXu, Z. / Zuo, Y. / Wang, J. / Yu, Z. / Peng, F. / Chen, Y. / Hu, X. / Bao, Y. / Chen, M. et al. | 2013
-
22O REBIOPSY IN TKI-RESISTANCE: A RETROSPECTIVE ANALYSISKuiper, J. / Heideman, D. / Thunnissen, E. / Paul, R. / Smit, E. et al. | 2013
-
50O PREDICTORS FOR RADIATION PNEUMONITIS AFTER SABR FOR HIGH-RISK LUNG TUMORSBongers, E. M. / Botticella, A. / Palma, D. A. / Warner, A. / Haasbeek, C. J. A. / Verbakel, W. F. A. R. / Slotman, B. J. / Ricardi, U. / Senan, S. et al. | 2013
-
81P CHEMOTHERAPY IN ELDERLY PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCERBensaou, M. G. / Allalouche, N. M. / Dlim, N. G. / Bouzid, K. et al. | 2013
-
87P THE PROGNOSTIC PREDICTORS OF 2ND LINE CHEMOTHERAPY IN ADVANCED NON-SMALL CELL LUNG CANCERChang, J. H. / Ryu, Y. J. / Lee, S. J. / Lee, J. H. et al. | 2013
-
116P RETROSPECTIVE ANALYSIS OF PATIENTS WITH THYMIC MALIGNANCIES TREATED AT THE VALL D'HEBRON UNIVERSITY HOSPITALMartinez, P. / Declara, I. M. / Martinez-Marti, A. / Cedres, S. / Navarro, A. / Fico, M. / De la Morena, P. / Salcedo, M. T. / Romero, L. / Felip, E. et al. | 2013
-
113P SARCOMA OF LUNG, PLEURAVoloshyn, Y. et al. | 2013
-
25PD CIRCULATING MICRO-RNA PROFILING IN PATIENTS WITH ADVANCED NON-SQUAMOUS NON SMALL-CELL LUNG CANCER RECEIVING BEVACIZUMAB/ERLOTINIB FIRST-LINE TREATMENT FOLLOWED BY PLATINUM-BASED CHEMOTHERAPY AT DISEASE PROGRESSION (SAKK 19/05)Joerger, M. / Baty, F. / Stahel, R. A. / Betticher, D. / von Moos, R. / Pless, M. / Gautschi, O. / Brauchli, P. / Zappa, F. / Brutsche, M. et al. | 2013
-
38PD CURRENT ROLE OF VATS IN THE DIAGNOSIS OF A MEDIASTINAL LYMPHADENOPATHY OF UNKNOWN ETIOLOGYLo Faso, F. / Solaini, L. / Lembo, R. / Bagioni, P. / Zago, S. / Pascotto, R. / Soliani, P. et al. | 2013
-
53P ROBOTIC RADIOSURGERY FOR INOPERABLE PATIENTS WITH STAGE IA-IB NON SMALL CELL LUNG CANCERBeltramo, G. / Bergantin, A. / Martinotti, A. S. / Vite, C. / Ria, F. / Invernizzi, M. / Bianchi, L. C. et al. | 2013
-
60P A RANDOMIZED TRIAL COMPARING CONVENTIONAL FRACTIONATION VERSUS ACCELERATED HYPERFRACTIONATION WITH THREE DIMENSIONAL CONFORMAL RADIOTHERAPY (3D-CRT) AND CONCURRENT CHEMOTHERAPY IN UNRESECTABLE NON SMALL CELL LUNG CANCERSapkota, S. / Kapoor, R. / Aggrawal, A. N. et al. | 2013
-
103P SERUM MARKERS OF BONE METABOLISM MEASUREMENT IN PATIENTS WITH BREAST CANCER AND LUNG METASTASISLumachi, F. / Marino, F. / Chiara, G. B. / Basso, S. M. M. et al. | 2013
-
1O THE LUNGPATH STUDY - OPTIMISING THE PATHOLOGICAL DIAGNOSIS OF LUNG CANCERCane, P. / Linklater, K. M. / Holmberg, L. / Moller, H. / Santis, G. et al. | 2013
-
9P RELATIONSHIP OF VEGF AND P16 EXPRESSION IN TUMOR AND TUMOR SURROUNDING TISSUE TO SPIROMETRY TESTS AND SURVIVAL OUTCOMES OF NON-SMALL-CELL LUNG CANCER PATIENTSJusufovic, E. / Sejdinovic, R. et al. | 2013
-
40PD SMALL CELL LUNG CANCER AND HYPONATREMIA: INTERIM RESULTS FROM A PROSPECTIVE, OBSERVATIONAL, GLOBAL REGISTRYMakin, A. / Greenberg, A. / Verbalis, J. / Grohe, C. et al. | 2013
-
61P PHYSICO-BIOLOGICAL TREATMENT PLAN OPTIMIZATION FOR INDIVIDUALIZED DOSE ESCALATION IN ADVANCED NON-SMALL CELL LUNG CANCER RADIOTHERAPY: MAXIMALLY ACHIEVABLE TUMOR DOSE VERSUS RISK OF RADIATION PNEUMONITISTroost, E. G. C. / Hoffmann, A. L. / Bussink, J. / Kaanders, J. H. A. M. et al. | 2013
-
93P A COMPARATIVE STUDY OF DOCETAXEL PLUS CISPLATIN COMPARED WITH GEMCITABINE PLUS CISPLATIN IN TREATING ADVANCED NON-SMALL CELL LUNG CANCERElHindawy, E. et al. | 2013
-
126P THE ANTI-TUMOR IMMUNE RESPONSES IN THROMBOCYTOPENIC MOUSE TUMOR MODELLee, S. Y. / Knoff, J. / Min, K. H. / Hur, G. Y. / Kim, J. H. / Shim, J. J. / In, K. H. / Kang, K. H. / Wu, T. C. / Hung, C. et al. | 2013
-
Translation research Index| 2013
-
21P CLINICOPATHOLOGICAL FEATURES OF ELDERLY PATIENTS WITH NSCLC; SINGLE INSTITUTIONAL EXPERIENCE FROM EGYPTShahin, M. / Abdelrhman, O. / Fouad, E. / Abdelmalek, R. / Azim, H. A. et al. | 2013
-
46P BASAL (PRE-TREATMENT) PET SCAN [MAXIMUM STANDARDIZED UPTAKE VALUES (SUVMAX)] AS A PROGNOSTIC FACTOR IN SMALL CELL LUNG CANCER PATIENTS WITH EXTENDED DISEASEAix, S. P. / Kopp, R. M. / Rubio, L. P. / Docampo, L. I. / Solis, S. R. / Nunez, J. A. / Martinez, T. P. et al. | 2013
-
62P IMPACT OF THE USE OF SIMULATION 18-FDG PET/CT ON TARGET VOLUMES AND DOSIMETRIC PARAMETERS IN THE TREATMENT OF LOCALLY ADVANCED NSCLC (NON SMALL CELL LUNG CANCER): PRELIMINARY RESULTS ON 35 PATIENTSFurfaro, I. F. / Scotti, V. / Pallotta, S. / Agresti, B. / Vanzi, E. / Franzese, C. / Simontacchi, G. / Casati, M. / Biti, G. et al. | 2013
-
109P DIFFICULTIES OF DIAGNOSIS, RESULTS OF TREATMENT OF SOLITARY AND DIFFUSIVE FORMS OF MESOTHELIOMAVoloshyn, Y. et al. | 2013
-
110P MALIGNANT PLEURAL MESOTHELIOMA: CLINICOPATHOLOGIC AND SURVIVAL CHARACTERISTICS IN A CONSECUTIVE SERIES OF 40 PATIENTSBagheri, R. / Haghi, S. Z. / Rahimi, M. / Attaran, D. / Toussi, M. S. et al. | 2013
-
3P FLUORESCENCE IN SITU HYBRIDIZATION (FISH) FOR DETECTION OF ALK REARRANGEMENTS VIA THINPREP CYTOLOGY PREPARATIONS IN NON SMALL CELL LUNG CARCINOMA (NSCLC)Tubbs, R. / Minca, E. / Reynolds, J. / Pennell, N. et al. | 2013
-
34P BRONCHIAL-PULMONARY CARCINOMA: PET SCAN SUVS AND MITOCHONDRIAL DNA COPY NUMBER CORRELATE WITH HISTOLOGICAL SUB-TYPINGCarvalho, L. / Dias, J. A. / Alarcao, A. / Silva, M. R. / Ladeirinha, A. F. / D'Aguiar, M. J. / Ferreira, T. / Bonifacio, C. / Santos, M. J. / Grazina, M. et al. | 2013
-
35 ROLE OF CXCL4 CHEMOKINE IN ANGIOGENIC ACTIVITY OF NON-SMALL CELL LUNG CANCER (NSCLC)Spaks, A. / Isajeva, D. / Spaka, I. / Pirtnieks, A. / Jaunalksne, I. / Grusina-Ujumaza, J. / Basko, J. / Taivans, I. / Krievins, D. et al. | 2013
-
58PD VATS LOBECTOMY AFTER INDUCTION THERAPY FOR LUNG CANCER: A SAFE AND EFFECTIVE METHODWu, Y. C. / Chao, Y. K. et al. | 2013
-
70PD EFFECT OF ENOBOSARM, A SELECTIVE ANDROGEN RECEPTOR MODULATOR, IN NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS WITH MUSCLE WASTING IN A PHASE IIB TRIALCroot, C. C. / Johnston, M. A. / Steiner, M. S. / Hancock, M. L. / Somer, B. G. et al. | 2013
-
99P PULMONARY METASTASECTOMY AND REPEATED METASTASECTOMY FOR SOFT TISSUE SARCOMABagheri, R. / Toussi, M. S. / Dayani, M. / Sheibani, S. et al. | 2013
-
101P PREOPERATIVE CEFAZOLIN PROPHYLAXIS PREVENTS SURGICAL SITE INFECTIONS IN PATIENTS UNDERGOING OPEN AND THORACOSCOPIC METASTASECTOMY FOR LUNG METASTASES. A CASE-CONTROL STUDYLumachi, F. / Mazza, F. / Camporese, A. / Del Conte, A. / Chiara, G. B. / Basso, S. M. M. et al. | 2013
-
112P EARLY DIAGNOSTIC OF THE PLEURAL CANCER OF PATIENTS WITH TUBERCULOSIS ETIOLOGICAL PLEURITISAliyev, K. / Mammadov, I. et al. | 2013
-
2PD ISOLATION AND CHARACTERIZATION OF CIRCULATING TUMOR CELLS IN ADVANCED SQUAMOUS-CELL CARCINOMA OF THE LUNGBozzetti, C. / Passaro, A. / Cavazzoni, A. / Carubbi, C. / Lagrasta, C. / Quaini, F. / Nicolazzo, C. / Gnetti, L. / Ardizzoni, A. / Tiseo, M. et al. | 2013
-
39P USEFULNESS OF ENDOBRONCHIAL ULTRASOUND IN THE DIAGNOSIS OF PERIPHERAL PULMONARY LESIONS IN A GENERAL HOSPITALKokkonouzis, I. / Lampaditis, I. / Charpdou, A. / Syrigos, K. N. et al. | 2013
-
42P THE PREDICTIVE SIGNIFICANCE OF LEPTIN, ADIPONECTIN, RESISTIN AND GHRELIN SERUM LEVELS AT DIAGNOSIS OF PATIENTS WITH SMALL CELL LUNG CANCERTourkantonis, I. / Kotteas, E. / Georgousopoulou, E. / Kainis, E. / Gkiozos, I. / Charpidou, A. / Syrigos, K. N. et al. | 2013
-
68O EFFICACY, SAFETY AND TOLERABILITY RESULTS FROM A PHASE IV, OPEN-LABEL, SINGLE ARM STUDY OF 1ST-LINE GEFITINIB IN CAUCASIAN PATIENTS (PTS) WITH EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) MUTATION-POSITIVE NON-SMALL-CELL LUNG CANCER (NSCLC)Douillard, J. / Ostoros, G. / Cobo, M. / Ciuleanu, T. / McCormack, R. / Webster, A. / Milenkova, T. et al. | 2013
-
91P GEFITINIB PLUS ZOLEDRONIC ACID ROLE IN BONE METASTASES FROM EGFR MUT+VE NSCLC PATIENTSDel Signore, E. / Gori, B. / D'Antonio, C. / Ricciardi, S. / Fulvi, A. / Migliorino, M. R. / Condo, S. / de Marinis, F. et al. | 2013
-
123PD PROGNOSTIC AND PREDICTIVE FACTORS IN PATIENTS WITH LUNG CANCER AND BRAIN METASTASESJochymek, B. D. / Suwinski, R. et al. | 2013
-
16P SIMPLE NANOPARTICLE-BASED ASSAY FOR DETECTION OF LUNG CANCER MICRORNAS BIOMARKERSVo-Dinh, T. / Wang, H. et al. | 2013
-
19P LUNG CANCER AS A SECOND MALIGNANCY AFTER INITIAL TREATMENT OF PRIMARY NON LUNG CANCER - A SINGLE INSTITUTION EXPERIENCENikolic, N. / Tomasevic, Z. / Radosavljevic, D. / Dimitrijevic, J. / Nikolic, V. et al. | 2013
-
43P CONDITIONAL PROBABILITY OF SURVIVAL IN SMALL CELL LUNG CANCERNaidoo, J. / Teo, M. Y. / Doyle, P. / Bazarbashi, A. / Sharial, M. S. N. M. / Clince, J. / Walshe, J. M. / Breathnach, O. S. et al. | 2013
-
51P STEREOTACTIC BODY RADIATION THERAPY IN OCTOGENARIANS WITH EARLY STAGE LUNG CANCERSandhu, A. P. / Lau, S. K. M. / Rahn, D. / Nath, S. K. / Kim, D. / Gulaya, S. / Fuster, M. M. / Bazhenova, L. / Mundt, A. J. et al. | 2013
-
90P ERLOTINIB VS CHEMOTHERAPY AS SECOND LINE THERAPY FOR PATIENTS WITH ADVANCED EGFRWT NON SMALL CELL LUNG CANCER. A SINGLE INSTITUTION EXPERIENCEGarde, J. / Garcia, J. / Berzosa, M. / Marin, S. / Sangrador, C. / Piera, N. / Hidalgo, J. / Juan, O. / Llombart, A. et al. | 2013
-
96PD PATTERN AND SURVIVAL OF LUNG METASTASIS IN YOUNG BREAST CANCER PATIENTS: A SINGLE CENTRE EXPERIENCEGogia, A. / Raina, V. / Mohanti, B. / Deo, S. / Shukla, N. et al. | 2013
-
97P MANAGEMENT OF LUNG METASTASES FROM COLORECTAL CANCER: VIDEO-ASSISTED THORACOSCOPIC SURGERY VERSUS THORACOTOMY - A CASE-MATCHED STUDYChao, Y. K. et al. | 2013
-
120P INTERVENTIONAL FLEXIBLE BRONCHOSCOPIC MANAGEMENT IN ENDOBRONCHIAL OBSTRUCTION: A SINGLE-CENTER EXPERIENCEAhn, J. H. / Kim, J. S. / Shin, A. Y. / Yoon, J. S. / Suh, J. H. / Kim, K. J. / Kay, C. S. / Kim, J. H. / Park, E. S. et al. | 2013
-
13P NON SQUAMOUS NSCLC IS MORE PLATINUM SENSITITVE THAN SQUAMOUS NSCLCFouad, E. / Abdelrhman, O. / Abdelmalek, R. / Shahin, M. / Azim, H. A. et al. | 2013
-
18P 'ASK THE EXPERT' PROMOTING EARLY DIAGNOSIS OF LUNG CANCERThomas, R. / Jackson, C. / Gilmartin, R. / Compton, S. / Tindale-Paul, P. / Colvin, M. et al. | 2013
-
24PD METABOLOMIC PROFILE OF LUNG CANCER PATIENTSPuchades-Carrasco, L. / Jantus-Lewintre, E. / Lucas, R. / Blasco, A. / Pineda-Lucena, A. / Camps, C. et al. | 2013
-
45P SMALL CELL LUNG CANCER (SCLC) IN ELDERLY PATIENTS (PTS)Unk, M. / Ovcaricek, T. / Sadikov, A. / Cufer, T. et al. | 2013
-
49O LUNG TRANSPLANTATION IN EARLY STAGE CARCINOMA OF THE EXPLANTED LUNG - IS IT A CURE FOR THE CANCER?Klikovits, T. / Hoda, M. A. / Ghanim, B. / Zgud, S. / Murakozy, G. / Klepetko, W. / Jaksch, P. et al. | 2013
-
55P COMBINED TREATMENT OF OPERABLE LUNG CANCER WITH DIFFERENT TYPES OF FRACTIONATION POSTOPERATIVE RADIOTHERAPYRagulin, Y. / Mardynsky, Y. / Medvedev, V. / Ivanova, I. / Kudryavtsev, D. / Kursova, L. et al. | 2013
-
76P PROLONGED PEMETREXED TREATMENT AS EVERY 4 WEEK SCHEDULE IN NON-SQUAMOUS NON-SMALL CELL LUNG CANCER PATIENTSKwon, J. H. / Kim, Y. J. / Lee, K. W. / Yoon, H. I. / Kim, J. H. / Lee, J. H. / Lee, C. T. / Lee, J. S. et al. | 2013
-
77P CLINICAL OUTCOMES OF CONTINUING EGFR RECEPTOR TYROSINE KINASE INHIBITORS AFTER RECIST PROGRESSION OF BONE METASTASIS IN EGFR-MUTANT NSCLCHong, S. H. / Jeon, E. / Kim, Y. S. / Kim, Y. / Chung, Y. / Kim, S. J. / Kang, J. et al. | 2013
-
84P MAINTENANCE LOW-DOSE GEMCITABINE VERSUS BEST SUPPORTIVE CARE IN ADVANCED AND METASTATIC NON-SMALL CELL LUNG CANCER: RANDOMIZED PHASE III TRIALNagy, A. A. / Fouad, E. / Nasr, K. / El-Ghazaly, H. / Adel, A. et al. | 2013
-
28P THE PROGNOSTIC SIGNIFICANCE OF THE STROMAL CELL MARKER SPARC IN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCERYun, H. J. / Ryu, H. / Lee, H. / Jo, D. Y. / Kim, S. / Lee, K. et al. | 2013
-
31P ALK ASSESSMENT WITH FISH, IHC AND AQUA IN GREEK NSCLC PATIENTSKotoula, V. / Kosmidis, P. / Bobos, M. / Vassilakopoulou, M. / Tsolaki, E. / Chrysafi, S. / Psyrri, A. / Fountzilas, G. et al. | 2013
-
36O 99MTC-ETARFOLATIDE (EC20) IMAGING TO IDENTIFY NSCLC PATIENTS LIKELY TO BENEFIT FROM VINTAFOLIDE (EC145) TREATMENTHarb, W. A. / Bonomi, P. / Symanowski, J. / Nguyen, B. / Edelman, M. et al. | 2013
-
73P GENE MUTATIONS IN SQUAMOUS-CELL NSCLC: INSIGNIFICANCE OF EGFR, KRAS AND PIK3CA MUTATIONS IN PREDICTION OF EGFR-TKI TREATMENT EFFICACYFiala, O. / Pesek, M. / Finek, J. / Benesova, L. / Bortlicek, Z. / Minarik, M. et al. | 2013
-
95O SURGICAL TREATMENT OF 549 PATIENTS WITH LUNG METASTASES FROM COLORECTAL CARCINOMA. INITIAL RESULTS OF A PROSPECTIVE SPANISH STUDYMolins, L. / Fibla, J. J. / Embun, R. / Rivas, F. / Heras, F. / De La Cruz, F. J. / Rubio, M. / Fernandez, E. / Carbajo, M. / Rivas, J. J. et al. | 2013
-
107P IMPACT OF PREINTERVENTIONAL PLASMA FIBRINOGEN AS A PROGNOSTIC MARKER IN MALIGNANT PLEURAL MESOTHELIOMAKlikovits, T. / Ghanim, B. / Hoda, M. A. / Winter, M. P. / Dome, B. / Jakopovic, M. / Samarzija, M. / Berger, W. / Klepetko, W. / Hegedus, B. et al. | 2013
-
122PD AGE SPECIFIC RISK ASSESSMENT IN SENIOR LUNG CANCER PATIENTSLukavetskyy, N. / Welter, S. / Stamatis, G. et al. | 2013
-
4P CLINICO-PATHOLOGICAL CHARACTERISTICS OF PATIENTS WITH LUNG ADENOCARCINOMA HARBOURING MUTATIONS IN THE EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) GENE IN THE SERBIAN POPULATIONZaric, B. / Stojsic, V. / Carapic, V. / Tepavac, A. / Sarcev, T. / Jankovic, R. / Perin, B. et al. | 2013
-
12P SUPEROXIDE DISMUTASE ACTIVITY AS A PREDICTIVE SIGN OF MALIGNANCY OF THE TUMOR PROCESS IN LUNG CANCER PATIENTSRagulin, Y. / Izmestyeva, O. / Zhavoronkov, L. / Vapnyar, V. / Derbugov, V. et al. | 2013
-
15O VOLUMETRIC COMPUTER TOMOGRAPHY SCREENING FOR LUNG CANCER: THREE ROUNDS OF THE NELSON TRIALHoreweg, N. / van der Aalst, C. / Vliegenthart, R. / Zhao, Y. R. / Xie, X. / Scholten, E. T. / Mali, W. / Thunnissen, E. / Oudkerk, M. / de Koning, H. et al. | 2013